Skip to content

Effects for intake of blue rose water on Salivary Oxytocin and cortisol.

Effects for intake of blue rose water on Salivary Oxytocin and cortisol. - Effects for intake of blue rose water on Salivary Oxytocin and cortisol.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052088
Enrollment
10
Registered
2023-09-01
Start date
2023-08-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

100 mL of the test product is ingested at the time of testing.

Sponsors

KINJIRUSHI Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Japanese healthy female subjects, between 20 years and 49 years old (inclusive) at the time of consent.

Exclusion criteria

Exclusion criteria: 1. Subjects who smoke tobacco. 2. Subjects who are alcoholic. 3. Subjects who have medical history that needs treatment or follow up. 4. Subjects who have some allergies of food or drug 5. Subjects who have plant allergy or allergic symptoms with aromatherapy. 6. Subjects who are taking medications that affect the autonomic nervous system. 7. Subjects who are olfactory disorder. 8. Subjects who participate in, at the time of initiation of this study, another test that interferes with this study or subjects who are scheduled to attend, during the tests, another test that interferes with this study. 9. Subjects who received chemical peel, laser treatment, light irradiation treatment, skin treatment such as injection, or surgery, or beauty therapy on the site of the skin test within 4 weeks by the start of the test. 10. Subjects who are judged as unsuitable by the investigator.

Design outcomes

Primary

MeasureTime frame
Salivary oxytocin 10 minutes before intervention and 10 minutes after intervention

Secondary

MeasureTime frame
Salivary cortisol 10 minutes before intervention and 1minutes after intervention Questionnaire

Countries

Japan

Contacts

Public ContactDaisuke Aoyagi

KINJIRUSHI Co., Ltd R&D Division

daisuke-aoyagi@kinjirushi.co.jp052-361-3859

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026